Nomura Holdings
KRTX

Nomura Holdings’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Nomura Holdings’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-33,762
Closed -$6.59M – 1825
2022
Q4 		$6.59M Sell
33,762
-9,809
-23% -$2.1M 0.03% 410
2022
Q3 		$9.81M Buy
+43,571
New +$8.82M 0.04% 354

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Nomura Holdings's KRTX Position: Q1 2023 in Review

Nomura Holdings sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2023, closing a stake of 33,762 shares — an estimated $6.59M sold.

Nomura Holdings first reported a position in KRTX in Q3 2022 and held it in 2 quarters. The position peaked at $9.81M in Q3 2022. 246 funds tracked by Wall St. Rank hold KRTX as of Q1 2023.

  • Nomura Holdings reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Nomura Holdings sold 33,762 Karuna Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $6.59M.
  • Nomura Holdings first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Nomura Holdings's Karuna Therapeutics, Inc. Common Stock position peaked at $9.81M in Q3 2022.
  • 246 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Nomura Holdings's 13F filing for Q1 2023, filed 15 May 2023.